Haga SB - Search Results

1

The potential of a placebo/nocebo effect in pharmacogenetics.

Haga SB, Warner LR, O'Daniel J. Haga SB, et al. Public Health Genomics. 2009;12(3):158-62. doi: 10.1159/000189628. Epub 2009 Feb 10. Public Health Genomics. 2009. PMID: 19204418 Free PMC article.

2

Adding pharmacogenetics information to drug labels: lessons learned.

Haga SB, Thummel KE, Burke W. Haga SB, et al. Pharmacogenet Genomics. 2006 Dec;16(12):847-54. doi: 10.1097/01.fpc.0000236322.88433.ac. Pharmacogenet Genomics. 2006. PMID: 17108808 Review.

3

Determining user preferences between touch and pen data entry methods in the Tablet PC computing environment.

Silvey GM, Haga SB, O'Daniel JM, Deverka P, Ermentrout DM, Anstrom KJ, Lobach DF. Silvey GM, et al. Among authors: haga sb. AMIA Annu Symp Proc. 2007 Oct 11:1115. AMIA Annu Symp Proc. 2007. PMID: 18694212

4

Factors influencing uptake of pharmacogenetic testing in a diverse patient population.

O'Daniel J, Lucas J, Deverka P, Ermentrout D, Silvey G, Lobach DF, Haga SB. O'Daniel J, et al. Among authors: haga sb. Public Health Genomics. 2010;13(1):48-54. doi: 10.1159/000217795. Epub 2009 May 4. Public Health Genomics. 2010. PMID: 19407441

5

Considerations for the impact of personal genome information: a study of genomic profiling among genetics and genomics professionals.

O'Daniel JM, Haga SB, Willard HF. O'Daniel JM, et al. Among authors: haga sb. J Genet Couns. 2010 Aug;19(4):387-401. doi: 10.1007/s10897-010-9297-x. Epub 2010 Mar 30. J Genet Couns. 2010. PMID: 20352309

6

Genomic risk profiling: attitudes and use in personal and clinical care of primary care physicians who offer risk profiling.

Haga SB, Carrig MM, O'Daniel JM, Orlando LA, Killeya-Jones LA, Ginsburg GS, Cho A. Haga SB, et al. J Gen Intern Med. 2011 Aug;26(8):834-40. doi: 10.1007/s11606-011-1651-7. Epub 2011 Feb 11. J Gen Intern Med. 2011. PMID: 21311998 Free PMC article.

7

Survey of US public attitudes toward pharmacogenetic testing.

Haga SB, O'Daniel JM, Tindall GM, Lipkus IR, Agans R. Haga SB, et al. Pharmacogenomics J. 2012 Jun;12(3):197-204. doi: 10.1038/tpj.2011.1. Epub 2011 Feb 15. Pharmacogenomics J. 2012. PMID: 21321582 Free PMC article.

8

Public perspectives regarding data-sharing practices in genomics research.

Haga SB, O'Daniel J. Haga SB, et al. Public Health Genomics. 2011;14(6):319-24. doi: 10.1159/000324705. Epub 2011 Mar 24. Public Health Genomics. 2011. PMID: 21430368 Free PMC article.

9

Public perspectives on returning genetics and genomics research results.

O'Daniel J, Haga SB. O'Daniel J, et al. Among authors: haga sb. Public Health Genomics. 2011;14(6):346-55. doi: 10.1159/000324933. Epub 2011 May 7. Public Health Genomics. 2011. PMID: 21555865 Free PMC article.

10

Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions.

Haga SB, O'Daniel JM, Tindall GM, Lipkus IR, Agans R. Haga SB, et al. Genet Med. 2011 Aug;13(8):723-8. doi: 10.1097/GIM.0b013e31821afcc0. Genet Med. 2011. PMID: 21633294 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters